ASPEN PHARMACR Stock Price (OTCMKTS:APNHY)

Add to My Stocks
$17.79 $0.21 (1.19%) APNHY stock closing price Aug 17, 2018 (Closing)
Prev Close* : $17.58
Market Cap:
$8.12B
Day Low: $17.59
52 Week Low: $17.50
Open: $17.62
Volume: -
Day High: $17.98
52 Week High: $24.60
Dividend:
0.15

Latest Stock Market News

Latest Articles

APNHY Stockcharts

View APNHY PE ratio, PS ratio stocks charts and compare with peers.
APNHY Chart
Note: Compare ASPEN PHARMACR stock price history with the index and industry peers.

ASPEN PHARMACR Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

ASPEN PHARMACR Returns

ROE
(return on equity)

ASPEN PHARMACR Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

APNHY Industry Peers

Company Price Change (%)
Teva Pharmaceutical (TEVA)24.220.11 (0.46%)
Mylan (MYL)38.150.3 (0.79%)
Bausch Health (BHC)21.890.2 (0.92%)
Dr. Reddy's Laboratories (RDY)33.830.52 (1.56%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Supernus Pharma (SUPN)44.81.3 (2.99%)
Corium (CORI)8.930.24 (2.76%)
Mallinckrodt (MNK)34.690.55 (1.61%)
Dr. Reddy's Laboratories (RDY)33.830.52 (1.56%)
BAUSCH HEALTH (BHC)21.890.2 (0.92%)
Mylan (MYL)38.150.3 (0.79%)
Allergan (AGN)185.61.39 (0.75%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)22.430.41 (1.8%)
Progenics Pharma (PGNX)7.810.08 (1.01%)
Akorn (AKRX)18.990.16 (0.84%)
Teligent (TLGT)4.260.01 (0.23%)
Top losers from Medical-Generic Drugs industry
* As of Aug 18, 2018

ASPEN PHARMACR Stock News - Partner Headlines

ASPEN PHARMACR Financial Statements

income statement20172016
Net Sales or Revenues3.03B2.47B
Net Income374.85M298.42M
Total Operating Expense852.6M617.66M
View ASPEN PHARMACR income statement
balance sheet20172016
Total Assets8.55B7.24B
Total Liabilities5.38B4.29B
Shareholders Equity3.17B2.95B
View ASPEN PHARMACR balance sheet
cash flow statement20172016
Net Increase (Decrease) in Assets Liabilities-66.14M-235.96M
Net Cash from (used by) Operating Activities477.75M222.08M
Increase (Decrease) in Prop Plant And Equipment-110.25M-117.98M
View ASPEN PHARMACR cash flow statement

ASPEN PHARMACR Stock Message Board

As of last trading day, ASPEN PHARMACR stock price was $17.79. Stock price or share price can be used to find the total market value of a company. ASPEN PHARMACR market cap stands at $8.12B as of Aug 17, 2018. ASPEN PHARMACR valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy APNHY stock than sell it, then ASPEN PHARMACR stock price goes up. Conversely, if more investors wanted to sell APNHY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in ASPEN PHARMACR stock quote data shows the number of shares traded. For Ex: 21,869 ASPEN PHARMACR shares were traded as of last trading day, as seen from ASPEN PHARMACR stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. ASPEN PHARMACR dividend per share was 0.15 during the last quarter. ASPEN PHARMACR stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.